Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Clin Breast Cancer. 2015 Jun 18;15(6):458–466. doi: 10.1016/j.clbc.2015.06.006

Figure 5.

Figure 5

Treatment administered based on (A) RS absolute number, (B) Ki67 proliferation index and (C) nuclear grade to patients with (1) pT1b disease with intermediate RS and (2) pT1c disease with intermediate RS.